Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Humans and Chimps Share Genetic Strategy in Battle Against Pathogens

Published: Tuesday, February 19, 2013
Last Updated: Tuesday, February 19, 2013
Bookmark and Share
Findings point to common ancestry.

A genome-wide analysis searching for evidence of long-lived balancing selection—where the evolutionary process acts not to select the single best adaptation but to maintain genetic variation in a population—has uncovered at least six regions of the genome where humans and chimpanzees share the same combination of genetic variants.

The finding, to be published Feb. 14 in the journal Science, suggests that in these regions, human genetic variation dates back to a common ancestor with chimpanzees millions of years ago, before the species split. It also highlights the importance of the dynamic co-evolution of human hosts and their pathogens in maintaining genetic variation.

Balancing selection allows evolution to keep all hereditary options open. The classic human example is the persistence of two versions of the hemoglobin gene: a normal version and hemoglobin S., a mutation that distorts the shape and function of red blood cells. Those who inherit two normal hemoglobin genes are at high risk for malaria, a parasitic disease that infects more than 200 million people each year. Those who inherit one normal gene and one hemoglobin S. gene are partially protected from malaria—a potentially life-saving benefit. Those with two copies of the gene suffer from sickle-cell anemia, a serious and lifelong circulatory disease.

“When we looked for genetic clues pointing to other, more ancient, examples of balancing selection, we found strong evidence for at least six such regions and weaker evidence for another 119—many more than we expected,” said study author Molly Przeworski, PhD, professor of human genetics and of ecology and evolution at the University of Chicago.

“We don’t yet know what their functions are,” she said. None of the six regions codes for a protein. There are clues that they are involved in host-pathogen interactions, “but which pathogens, what immune processes,” she said, “we don’t know.”

The researchers used genetic data from 10 chimpanzees from Western Africa and 59 humans from sub-Saharan Africa who were part of the 1,000 Genomes Project.

The scientists looked for cases in which genetic variations that arose in the ancestor of humans and chimpanzees have been maintained through both lines. The fact that variation in these regions of the genome has persisted for so long argues that they “must have been functionally important over evolutionary time,” said Ellen Leffler, a graduate student in Przeworski’s laboratory and first author of the study.

The researchers, from the University of Chicago and Oxford University, designed the study to be very conservative. “We wanted to find the cases we believed the most, rather than the most cases,” Przeworski said.

Computers sorted snippets of the genetic data from humans and chimps into clusters, depending on how similar the subjects were to each other. For almost every snippet, they found a cluster of humans and a separate cluster of chimpanzees, as expected. But there were a few segments of the genomes in which each cluster included both chimpanzees and humans; in those regions, some humans were more closely related to some chimpanzees than to other humans.

“Instances in which natural selection maintains genetic variation in a population over millions of years are thought to be extremely rare,” the authors wrote. The oldest and best known example of balanced polymorphism shared between humans and chimpanzees is the major histocompatibility complex (MHC), a group of genes that help the immune system distinguish between the body and potential invaders, such as bacteria or viruses.

Last year, a team led by Przeworski found that humans and gibbons shared genetic variation related to the ABO blood-group system from a common ancestor.
The six new examples of balanced selection described in this study appear to play a role, like the

MHC, in fending off infectious disease. This requires a variety of evolutionary tools, including balancing selection. When a population moves to a new environment—for example the exodus out of Africa to northern Europe—they face many one-time adjustments, such as adapting to less intense sunlight and decreased ultraviolet radiation. Over many generations, their offspring manage to decrease melanin production—a static adaptation for a static environment.

Fighting off pathogens is more dynamic, a constant arms race. Balancing selection may have enabled humans and chimps to retain multiple lines of defense that can be called on when a pathogen evolves new weapons.

“Our results imply that dynamic co-evolution of human hosts and their pathogens has played an important role in shaping human variation,” Przeworski said. “This highlights the importance of a different kind of selection pressure in human evolution.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Long-sought Genetic Model of Common Infant Leukemia Described
Researchers from the University of Chicago have created the first mouse model for Pro-B acute lymphoblastic leukemia.
Tuesday, November 15, 2016
Including the Microbiome in Precision Medicine
Scientists suggest microbiome plays a significant enough role in human health that studies should be a part of future precision medicine initiatives.
Wednesday, November 02, 2016
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Wednesday, October 26, 2016
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
Wednesday, September 14, 2016
Liquid Crystal Manipulation Controls Drug-Delivery Process
Scientists have turned liquid crystals into a tool to control the shape of synthetic cell membranes.
Tuesday, September 13, 2016
Grad Student's Finding Enables Rapid Compound Screening
Grad student makes technical leap that could enable rapid screening of anti-cancer compounds.
Friday, August 19, 2016
From Fins to Fingers
New gene-editing methods help the mapping of cells linking fish fins and mammalian limbs.
Friday, August 19, 2016
New Technique Targets Ataxia Gene
Scientists selectively turn off the disease-causing portion of a gene that causes a severe form of ataxia.
Thursday, July 14, 2016
Organ Behaviour Manipulation Possible with New Injectable
Scientists develop injectable that could be used to stimulate nerve cells and manipulate muscle and organ behaviour.
Friday, July 08, 2016
New Microbiome Center to Merge Expertise of UChicago, MBL and Argonne
Researchers to study world of microbes across environments.
Wednesday, May 18, 2016
AbbVie, University of Chicago Collaborate
The University of Chicago and AbbVie have entered into a five-year collaboration agreement designed to improve the pace of discovery and advance medical research in oncology at both organizations.
Thursday, April 21, 2016
New Code for Control of Gene Expression
A new cellular signal discovered by a team of scientists at the University of Chicago and Tel Aviv University provides a promising new lever in the control of gene expression.
Thursday, February 18, 2016
Bacterial Circadian Clocks Set by Metabolism, Not Light
New study finds that metabolism is the primary driver of the circadian rhythm.
Monday, December 14, 2015
New Nanomanufacturing Technique Advances Imaging, Biosensing Technology
Researchers invent a novel way to build nanolenses in large arrays using a combination of chemical and lithographic techniques.
Thursday, December 10, 2015
Enormous Genetic Variation May Shield Tumors from Treatment
Debate over Darwinian selection vs. random mutations emerges at the tumor level.
Wednesday, November 11, 2015
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Unique Visual Stimulation May Be New Treatment for Alzheimer’s
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Major Neuroscience Initiative Launched
Tianqiao and Chrissy Chen Institute invest $115 million to further expand neuroscience research, while Caltech construct $200 million biosciences complex.
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!